Fingerprint
Dive into the research topics where Lei Feng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
Lee, H. C., Becnel, M. R., Feng, L., Pasvolsky, O., Murga, A., Johnson, R. J., Thomas, S. K., Bashir, Q., Qazilbash, M. H., Steiner, R., Iyer, S. P., Weber, D. M., Patel, K. K., Kaufman, G. P., Manasanch, E. E. & Orlowski, R. Z., Jun 2026, In: American journal of hematology. 101, 6, p. 1187-1191 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
A Pilot Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (The GAMING-ON Study)
Cata, J. P., Guerra-Londono, J. J., Aveni, P., Cortes-Mejia, N., Gloria, J. M., Choi, J. E., Kim Hye, M., Owusu-Agyemang, P., Feng, L., Fuller, C., Beel, E. R. & Sinton, J., Apr 2026, In: Paediatric Anaesthesia. 36, 4, p. 352-360 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICU
and the Chimeric Antigen Receptor for the ICU (CAR-ICU) Initiative, Mar 1 2026, In: Critical care medicine. 54, 3, p. 422-434 13 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Akkad, N., Feng, L., Westin, J. R., Hagemeister, F. B., Lee, H. J., Fayad, L., Ahmed, S., Nair, R., Rodriguez, M. A., Strati, P., Chihara, D., Flowers, C. R., Claret, L., Ibanez, K., Wang, M., Fowler, N., Henderson, J., Davis, R. E., Neelapu, S. S. & Green, M. & 1 others, , Sep 9 2025, In: Blood Advances. 9, 17, p. 4396-4404 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma
Strati, P., Feng, L., Tyshevich, A., Shavronskaya, D., Alesse, J., English, N., Sheehan, E., Syzrantsev, N., Nesmelov, A., Zhuang, T. Z., Chihara, D., Westin, J. R., Ahmed, S., Fayad, L. E., Henderson, J., Dent, K., McChesney, E., Neelapu, S. S. & Flowers, C. R., Oct 1 2025, In: Clinical Cancer Research. 31, 19, p. 4079-4088 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations